XCUR News and Press, Exicure Inc. From 03/25/22

Continues to advance preclinical discovery of its SCN9A research program, anticipates reporting results from initial in vivo animal studies by year-end 2022 Continues progression of work with partnered programs, with plan of meeting potential pre-clinical milestones in 202...

3 Trending Penny Stocks For Your Watchlist Right Now When it comes to penny stocks, investors need to understand which ones are worth buying and which are not. In order to find penny stocks that are worth buying, you need to look at a few different factors. First, consider the compa...

NEW YORK, March 02, 2022 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that it is investigating whether the directors and/or officers of Exicure, Inc (“Exicure” or the “Company”) (NASDAQ: XCUR) breached their fiduciary duties of loyalty, good faith ...

Brian C. Bock to resign as President and CEO and become Special Advisor to the CEO for a transition period Dr. Matthias Schroff appointed President and CEO; will replace Mr. Bock on Board of Directors Timothy P. Walbert, Bosun Hau, and Andrew Sassine to resign from the Board o...

3 Reddit Penny Stocks For Your Watchlist Right Now Finding penny stocks on Reddit is one of the most popular places to gain ideas for a trading strategy. And as a result, many investors look to the social media site daily to find the best penny stocks to buy. Now, there are a few th...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investor! We’re kicking off another busy day of trading with a look at the biggest pre-market stock movers for Wednesday! Source: ventdusud / Shutterstock.com Moving stocks this morning are earn...

Exicure (XCUR +10.8%) entered into a definitive agreement with several institutional investors for the purchase and sale of 34.6M shares and warrants to purchase up to 17.3M shares at an effective purchase price of $0.3326/share in a registered direct offering priced at-the-market. The w...

Exicure, Inc.® (NASDAQ:XCUR), a pioneer in gene regulatory drugs utilizing spherical nucleic acid (SNA™) technology, today announced that it has entered into a definitive agreement with several institutional investors for the purchase and sale of 34,576,068 shares of the Com...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! It’s time to start off the day with a breakdown of the biggest pre-market stock movers for Tuesday! Source: f11photo/Shutterstock.com Moving stocks this morning are acquisitions, researc...

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Exicure To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - December 13, 2021) - Faruqi & Faruqi, LLP, a leading national securities law firm...